483
GlaxoSmithKline Biologicals SAFDA 483 - GlaxoSmithKline Biologicals SA
Record Details
GlaxoSmithKline Biologicals SA, a vaccine manufacturer in Rixensart, Belgium, was cited for multiple deficiencies during an FDA inspection. Observations included inadequate laboratory controls, insufficient investigation into Water for Injection contamination, deficient corrective actions, and poor equipment maintenance. These issues indicate a need for improved quality systems and adherence to manufacturing standards.
- Product Type
- Biologics
Open in Dashboard
ID · 2460b5ec-845d-4add-905f-e53591d5c1f2